🇺🇸 FDA
Patent

US 12251397

Cross-linked hyaluronic acids and combinations with PRP/BMC

granted A61KA61K31/194A61K31/728

Quick answer

US patent 12251397 (Cross-linked hyaluronic acids and combinations with PRP/BMC) held by REGEN LAB SA expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGEN LAB SA
Grant date
Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/194, A61K31/728, A61K31/738, A61K35/16